BPC-157 vs TB-500
Which healing peptide should you start with, and do you need both?
Reviewed by the amino101 editorial team. , first published .
BPC-157 and TB-500 are the two peptides people reach for after an injury, and they get lumped together so often that many assume they do the same thing. They do not. BPC-157 is a short gastric peptide that works locally, driving new blood vessel growth and fibroblast migration at the injury site. TB-500 is a fragment of thymosin beta-4, a much larger protein that regulates actin in every cell, and it acts on the whole body, promoting cell migration and reducing inflammation wherever it circulates.
| BPC-157 | TB-500 | |
|---|---|---|
| Typical dosage | 250 to 500 mcg | 2 to 5 mg |
| Frequency | once or twice daily | twice weekly during loading, then weekly or every other week |
| Route | Subcutaneous, Intramuscular, Oral | Subcutaneous, Intramuscular |
| Half-life | under 30 minutes in plasma (estimated); tissue effects last much longer | roughly 1 to 2 hours in plasma (estimated); the full protein persists longer in tissue |
| Cycle | 4 to 8 weeks | 4 to 6 week loading phase, then maintenance or stop |
| Research level | Limited research | Limited research |
| Human trials | Small pilots | Randomized trials |
| Status | Investigational, not FDA approved. Prohibited by WADA for athletes. | Investigational, not FDA approved. Prohibited by WADA for athletes. |
| Effects timeline | pain and swelling 3 to 7 days, tendon and muscle function 2 to 4 weeks, gut symptoms 1 to 3 weeks | flexibility and reduced stiffness 1 to 2 weeks, injury recovery 4 to 6 weeks |
Key differences
BPC-157 vs TB-500 dosage
Dosage patterns reported in research and community protocols, by goal. Taken from each compound page. Not a prescription.
| Goal | Dosage | Frequency |
|---|---|---|
| Acute soft tissue injury | 500 mcg | twice daily |
| Chronic tendon or ligament issue | 250 to 500 mcg | once daily |
| Gut complaints | 250 to 500 mcg | once or twice daily |
| General recovery | 250 mcg | once daily |
| Goal | Dosage | Frequency |
|---|---|---|
| Loading phase | 2 to 2.5 mg | twice weekly |
| Maintenance | 2 mg | every 1 to 2 weeks |
| Acute injury, higher end | 5 mg | twice weekly for 2 to 4 weeks |
| Flexibility and general recovery | 2 mg | once weekly |
Convert any of these to syringe units in the dosage calculator.
Side effects compared
- ▲Injection site redness or mild irritation
- ▲Nausea, more often with oral capsules
- ▲Headache or brief dizziness after a dose
- ▲Transient fatigue or a warm flush shortly after injection
- ▲Rare reports of mood changes, possibly tied to its dopamine and serotonin effects in animals
- ▲Fatigue, lethargy or a head rush for a few hours after larger doses
- ▲Headache
- ▲Injection site redness or mild bruising
- ▲Nausea or flushing shortly after a dose
- ▲Occasional lightheadedness on standing
Which should you choose?
BPC-157 is the better fit when you can point at the problem: one tendon, one ligament, a gut lining issue. It is cheaper, commonly reported at 250 to 500 mcg once or twice daily, and the rodent data supports injecting near the site. Start here if this is your first healing peptide and the injury is localized.
TB-500 makes more sense when the problem is spread out or cannot be localized: whole body soreness, several nagging sites, or recovery after a hard block of training. It is dosed in milligrams, commonly 2 to 5 mg twice weekly during a loading phase, and circulates systemically, so injection site does not matter. Expect to spend more per month.
For a single tendon or joint problem, start with BPC-157 alone. It is cheaper, the local mechanism matches the injury, and you will know within three weeks whether it is helping. Add TB-500 when the problem is diffuse, when several areas hurt at once, or when BPC-157 alone plateaus. The two are commonly stacked because the mechanisms are different, not because either one is incomplete. If you buy the combined Wolverine blend you are committing to both from day one, which makes sense for a serious injury and is overkill for a sore elbow.
Stacking: Both at once is the most common healing stack. Typical split is BPC-157 daily near the injury and TB-500 twice weekly anywhere.
BPC-157 is a 15 amino acid fragment of a protective protein found in human gastric juice. People use it for tendon, ligament, muscle and gut healing, and it is one of the most widely used research peptides in the recovery space.
TB-500 is a synthetic version of the active region of thymosin beta-4, a protein found in nearly every human cell that regulates actin and cell movement. It is used for injury recovery, flexibility and general tissue repair, usually alongside BPC-157.
BPC-157 vs TB-500: frequently asked
Can you take BPC-157 and TB-500 together?
Yes, and most people who use both do. The mechanisms are different, local growth factor signaling versus systemic cell migration, so they do not compete. The common pattern is BPC-157 daily near the injury and TB-500 twice weekly anywhere. The combination is sold pre-mixed as the Wolverine stack; see the BPC-157 and TB-500 stack for how the two are usually run.
Which is better for tendon injuries, BPC-157 or TB-500?
BPC-157 has the more specific tendon evidence. Rat studies show faster healing of cut Achilles tendons and improved tendon to bone reattachment. TB-500 helps with tendons too, but its data is broader and less targeted. For a single tendon, BPC-157 first; add TB-500 if several sites are involved.
Is BPC-157 or TB-500 better for muscle recovery?
TB-500 is the usual pick for general muscle recovery because it works systemically and reduces inflammation wherever it circulates. BPC-157 has good rodent data on muscle crush injuries but is best used when there is a specific tear. Both lack controlled human trials, so these are mechanism based preferences, not proven outcomes.
How long does BPC-157 take to work compared to TB-500?
BPC-157 users commonly report less pain and swelling within 3 to 7 days and functional improvement by 2 to 4 weeks. TB-500 is usually run with a 4 to 6 week loading phase before anyone judges it. Neither is instant, and neither replaces rehab.
Is BPC-157 or TB-500 legal?
Neither is approved as a drug anywhere, and both are prohibited by WADA for athletes. In the US, BPC-157 has been through a confusing regulatory stretch: barred from compounding in 2023, removed from that category in April 2026, and recommended for the 503A bulks list by a non-binding advisory vote in July 2026. Nothing about that clears it for sale as a medicine. Both are sold as research chemicals.
Related reading
Soft tissue and tendon injury recovery
Skin, scar and post-procedure healing
Healing with inflammation and gut support
Gut lining repair and inflammation control
Both are gut peptides. One repairs, one calms inflammation. Which problem do you have?
Same first name, nothing else in common. Which thymosin do you actually want?
Sources
- Achilles tendon healing in rats with BPC 157, tendon-to-bone reattachment. Journal of Orthopaedic Research, 2003
- Thymosin beta 4 accelerates wound healing. Journal of Investigative Dermatology, 1999